Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127013931 | 12701393 | 1 | I | 20160718 | 20160805 | 20160831 | 20160831 | EXP | GB-MHRA-ADR 23595231 | GB-009507513-1608GBR005501 | MERCK | 0.00 | M | Y | 0.00000 | 20160831 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127013931 | 12701393 | 1 | PS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | DAY 1-4 AND DAY 8-11 (40 MG) | U | 12675 | 40 | MG | TABLET | ||||||
| 127013931 | 12701393 | 2 | SS | THALIDOMIDE | THALIDOMIDE | 1 | Unknown | 200 MG, 1D | 12600 | MG | Y | U | 0 | 200 | MG | QD | |||
| 127013931 | 12701393 | 3 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | 1.3 MG/M2, UNSPECIFIED | Y | U | 0 | 1.3 | MG/M**2 | ||||||
| 127013931 | 12701393 | 4 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | REDUCED DOSE (1 MG/M2) | Y | U | 0 | 1 | MG/M**2 | ||||||
| 127013931 | 12701393 | 5 | C | POSACONAZOLE | POSACONAZOLE | 1 | Oral | 0 | TABLET | ||||||||||
| 127013931 | 12701393 | 6 | C | ACYCLOVIR. | ACYCLOVIR | 1 | Oral | 0 | |||||||||||
| 127013931 | 12701393 | 7 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | TABLET | ||||||||||
| 127013931 | 12701393 | 8 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127013931 | 12701393 | 1 | Plasma cell myeloma |
| 127013931 | 12701393 | 2 | Plasma cell myeloma |
| 127013931 | 12701393 | 3 | Plasma cell myeloma |
| 127013931 | 12701393 | 5 | Product used for unknown indication |
| 127013931 | 12701393 | 6 | Product used for unknown indication |
| 127013931 | 12701393 | 7 | Product used for unknown indication |
| 127013931 | 12701393 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127013931 | 12701393 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127013931 | 12701393 | Constipation | |
| 127013931 | 12701393 | Large intestine perforation | |
| 127013931 | 12701393 | Neuropathy peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127013931 | 12701393 | 1 | 201605 | 0 | ||
| 127013931 | 12701393 | 2 | 20160517 | 20160718 | 0 | |
| 127013931 | 12701393 | 3 | 20160720 | 0 | ||
| 127013931 | 12701393 | 4 | 20160722 | 0 |